Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine.

Stein, Daniel S

Open-label, single-dose, parallel-group study in healthy volunteers to determine the drug-drug interaction potential between KAE609 (cipargamin) and piperaquine. [electronic resource] - Antimicrobial agents and chemotherapy 2015 - 3493-500 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1098-6596

10.1128/AAC.00340-15 doi


Adolescent
Adult
Dose-Response Relationship, Drug
Drug Interactions
Female
Healthy Volunteers
Humans
Indoles--administration & dosage
Male
Middle Aged
Quinolines--administration & dosage
Spiro Compounds--administration & dosage
Young Adult